Tailored insights, in real-time, from your global clinical experts.
Pharmaceutical companies operate in one of the most competitive and fast-moving industries in the world. With mounting pressures to bring therapies to market faster and
Earlier this year, the FDA approved a new targeted chemotherapy, Datroway (datopotamab deruxtecan) for adults with unresectable or metastatic hormone receptor (HR)-positive, HER2 negative breast
Recently, the FDA approved pembrolizumab for adults with resectable locally advanced head and neck squamous cell carcinoma (HNSCC). The treatment is approved as a neoadjuvant
The best that can be hoped for in a new clinical trial or new treatment for aggressive forms of cancer is that patients gain time.